<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02501668</url>
  </required_header>
  <id_info>
    <org_study_id>2015-05-005</org_study_id>
    <nct_id>NCT02501668</nct_id>
  </id_info>
  <brief_title>The Prevalence of Lung Cancer in Patients With Interstitial Lung Disease</brief_title>
  <official_title>The Prevalence of Lung Cancer in Patients With Interstitial Lung Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Keimyung University Dongsan Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Keimyung University Dongsan Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will evaluate the prevalence of lung cancer associated with interstitial&#xD;
      lung disease (ILD) and idiopathic pulmonary fibrosis (IPF) utilizing the Korean Health&#xD;
      Insurance Review and Assessment Service (HIRA) database, spanning the period from January&#xD;
      2011 to December 2011. The database (HIRA-NPS-2011-0001) was based on random sampling of&#xD;
      outpatients from whole population. Patients with ILDs, IPF, connective tissue disorder (CTD),&#xD;
      and COPD were identified based on the International Classification of Disease-10 (ICD-10)&#xD;
      diagnostic codes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The epidemiology of lung cancer related to interstitial lung disease (ILD) with or without&#xD;
      with connective tissue disease (CTD) as well as idiopathic pulmonary fibrosis (IPF) has not&#xD;
      been well established yet. Interstitial lung disease has a potential to develop lung cancer&#xD;
      in the name of scar cancer. The investigators aimed to explore prevalence of lung cancer in&#xD;
      patients with ILD with or without CTD and IPF in comparison with chronic obstructive&#xD;
      pulmonary disorder (COPD).&#xD;
&#xD;
      The investigators will evaluate the prevalence of lung cancer associated with ILD and IPF&#xD;
      utilizing the Korean Health Insurance Review and Assessment Service (HIRA) database, spanning&#xD;
      the period from January 2011 to December 2011. The database (HIRA-NPS-2011-0001) was based on&#xD;
      random sampling of outpatients from whole population. The sample cases are total 1,375,842.&#xD;
      Among them 670,258 cases (age &gt; 40) were evaluated. Patients with ILDs, IPF, CTD, and COPD&#xD;
      will be identified based on the International Classification of Disease-10 (ICD-10)&#xD;
      diagnostic codes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Actual">July 2015</completion_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Lung cancer prevalence</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>Lung cancer prevalence in different groups</description>
  </primary_outcome>
  <number_of_groups>11</number_of_groups>
  <enrollment type="Actual">1375842</enrollment>
  <condition>Lung Diseases, Interstitial</condition>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Lung cancer in population</arm_group_label>
    <description>Lung cancer cases in sample population (670,258 cases)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>COPD in population</arm_group_label>
    <description>COPD cases (670,258 cases)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>COPD with lung cancer</arm_group_label>
    <description>Lung cancer in COPD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ILD without IPF</arm_group_label>
    <description>Interstitial lung disease (ILD) cases without idiopathic pulmonary fibrosis (IPF)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ILD with lung cancer</arm_group_label>
    <description>Lung cancer cases in ILD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Idiopathic pulmonary fibrosis</arm_group_label>
    <description>Idiopathic pulmonary fibrosis cases</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IPF with lung cancer</arm_group_label>
    <description>Lung cancer cases in IPF patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Connective tissue disorder with ILD</arm_group_label>
    <description>CTD with ILD cases</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CTD ILD with lung cancer</arm_group_label>
    <description>Lung cancer cases in CTD with ILD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CTD without ILD</arm_group_label>
    <description>CTD with ILD cases in sample population</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CTD without ILD with lung cancer</arm_group_label>
    <description>Lung cancer in CTD without ILD</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        This is a retrospective cohort study based on data collected from the HIRA national&#xD;
        database. HIRA is a government-affiliated organization that builds an accurate claims&#xD;
        review and is a quality assessment system for the National Health Insurance (NHI). The NHI&#xD;
        is the only public medical insurance system operated by the Ministry of Health and Welfare&#xD;
        in Korea.&#xD;
&#xD;
        Korean Health Insurance Review and Assessment Service (HIRA) provided sample database,&#xD;
        spanning the period from January 2011 to December 2011. The database (HIRA-NPS-2011-0001)&#xD;
        was based on random sampling of outpatients from whole population. The sample cases are&#xD;
        total 1,375,842. Among them 670,258 cases (age &gt; 40) were evaluated.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  equal to above 40 years old&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  none&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Won-Il Choi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Keimyung Unversity Dongsan Medical Center</affiliation>
  </overall_official>
  <verification_date>July 2015</verification_date>
  <study_first_submitted>July 11, 2015</study_first_submitted>
  <study_first_submitted_qc>July 16, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 17, 2015</study_first_posted>
  <last_update_submitted>July 16, 2015</last_update_submitted>
  <last_update_submitted_qc>July 16, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 17, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Keimyung University Dongsan Medical Center</investigator_affiliation>
    <investigator_full_name>Won-Il Choi</investigator_full_name>
    <investigator_title>Assoicate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Interstitial</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

